anemia
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase.
<span class="gene" id="15160343-0-0-14">Erythropoietin</span> is effective in improving the <span class="disease" id="15160343-0-45-51">anemia</span> induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase.